Immunocore Holdings Plc (IMCR)
35.36
-0.77
(-2.13%)
USD |
NASDAQ |
Sep 08, 16:00
35.32
-0.04
(-0.11%)
After-Hours: 20:00
Immunocore Holdings Debt to Equity Ratio : 1.036 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.036 |
| March 31, 2026 | 1.107 |
| December 31, 2025 | 1.146 |
| September 30, 2025 | 1.099 |
| June 30, 2025 | 1.124 |
| March 31, 2025 | 1.147 |
| December 31, 2024 | 1.200 |
| September 30, 2024 | 1.273 |
| June 30, 2024 | 1.317 |
| March 31, 2024 | 1.315 |
| December 31, 2023 | 0.2278 |
| September 30, 2023 | 0.2415 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.2423 |
| March 31, 2023 | 0.2486 |
| December 31, 2022 | 0.2486 |
| September 30, 2022 | 0.2513 |
| June 30, 2022 | 0.4111 |
| March 31, 2022 | 0.3963 |
| December 31, 2021 | 0.3721 |
| September 30, 2021 | 0.3204 |
| June 30, 2021 | 0.2845 |
| March 31, 2021 | 0.2595 |
| December 31, 2020 | 1.154 |
| December 31, 2019 | 4.022 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Silence Therapeutics Plc | 0.0029 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 0.0332 |
| Mereo BioPharma Group Plc | 0.0359 |
| Compass Pathways Plc | 0.6462 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.119B |
| Total Liabilities (Quarterly) | 699.62M |
| Shareholders Equity (Quarterly) | 419.80M |
| Current Ratio | 4.469 |
| Net Debt Paydown Yield | -0.01% |